SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules.
Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.
Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their R&D goals
Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.
91st position overall and the only CRDMO featured in the pharmaceutical sector
Adjudged Best Biologics CMO in South Asia by IMAPAC
Syngene has been awarded a Silver EcoVadis Medal for FY 2024, placing us among the top 15% of companies assessed.
91st position overall and the only CRDMO featured in the pharmaceutical sector
Adjudged Best Biologics CMO in South Asia by IMAPAC
We offer clients a customized end-to-end solution to fulfil their R&D and manufacturing requirements. Our approach enables us to forge client relationships that move beyond the traditional service outsourcing model into true end-to-end collaborations.
Our Discovery Services span the entire spectrum of early stage research from target …
Our Development Services encompass activities from pre-clinical to clinical trials…
Our Manufacturing services include cGMP-compliant facilities for clinical supplies, registration batches…
Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support…
Syngene InstaVisit is an interactive virtual experience designed to give you a 360 degree view of Syngene’s world-class facilities and capabilities. The platform allows you to change your perspective, look around and zoom in as we take you on a guided tour of Syngene’s labs.
Active Clients
Collaborations with top 20 Pharma/Biotech companies
Scientists
Mn sq. ft. of R&D and manufacturing infrastructure
Patents
© 2024. Syngene International Limited